Straube Richard 4
4 · SOLIGENIX, INC. · Filed Dec 13, 2019
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
Straube Richard
Sr VP & Chief Medical Officer
Transactions
- Award
Option (Right to Buy)
2019-12-12+30,000→ 30,000 totalExercise: $1.24From: 2019-12-12Exp: 2029-12-11→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock option vested immediately as to 7,500 shares and vests as to the remainder at a rate of 1,875 of the shares on each three (3) month anniversary of December 12, 2019.